QA: Arcturus Therapeutics Ltd in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001566049_2019_Arcturus_Therapeutics_Ltd.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001566049, Arcturus Therapeutics Ltd

  xvar xval
0 AssetsCurrent 41,828,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,975,000
3 remainder_Assets 395,000
4 LiabilitiesCurrent 12,577,000
5 LiabilitiesNoncurrent 9,911,000
6 remainder_Liabilities 8,068,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,582,000
9 ResearchAndDevelopmentExpense 16,982,000
10 remainder_Expenses 0
11 remainder_Revenues 15,753,000
12 remainder_NetIncome 26,000
13 remainder_ComprehensiveNetIncome 3,000
  yvar yval
0 Assets 44,198,000
1 Liabilities 30,556,000
2 Expenses 37,564,000
3 Revenues 15,753,000
4 StockholdersEquity 13,642,000
5 NetIncome -21,785,000
6 ComprehensiveNetIncome -21,783,500
7 BaseVar 64,050,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.213
9 EconomicCapitalRatio 1.62

Edgar->Model Mapping

Feature Distribution